PK MED is a pioneering French biotech company, privately owned and founded in 2019 in Lyon, France, with the backing of Truffle Capital, a leading European venture capital firm specializing in life sciences.
Built around a dedicated team of passionate and seasoned experts in pharmaceutical sciences, drug delivery, and biomaterials design, PK MED combines innovation and expertise to develop cutting-edge solutions in healthcare.
PK MED specializes in the development of innovative, custom-designed, injectable, and biodegradable micro-implants, leveraging its expertise to address critical healthcare challenges. Our focus lies in advanced drug delivery systems for rheumatology and pioneering cell-homing techniques to enhance the success of bone marrow transplantation.
Driven by a commitment to unmet medical needs, PK MED has built a promising portfolio of early-stage projects targeting key therapeutic areas, including gout flares, osteoarthritis, and hemoglobinopathies
Company Details
- Employees
- 11
- Founded
- 2019
- Address
- 14, Rue Jean-Antoine De Baïf, Paris,île-De-France 75013,france
- Industry
- Biotechnology
- Website
- http://www.pk-med.com
- Keywords
- Drug Delivery, Drug reformulation, Drug repurposing, Biomaterials, Pharmaceuticals, Biotechnology, BioTech, Innovation, Sustained Release.
- HQ
- Paris, Île-de-France
Pk Med Questions
Pk Med's website is http://www.pk-med.com
Pk Med's LinkedIn profile is https://fr.linkedin.com/company/pk-med
Pk Med has
11 employees.
View email and phone details for 11
employees at Pk Med.
Pk Med's industry is
Biotechnology
Pk Med's top competitors are
Bariatek,
Artedrone,
Adocia,
Caranx Medical,
Holistick Medical,
Alyve Medical,
Avadel Pharmaceuticals Plc,
Spikimm,
Mirai Medical,
Skinosive.
Pk Med's categories are Biotechnology
Pk Med's founding year is 2019
